1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ISTH0036: new trials by email Literature Review of ISTH0036 trials Research Report on ISTH0036
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy TGF-β2 antisense oligonucleotide, Trabeculectomy - Primary Open Angle Glaucoma | Phase 1 | Completed | Isarna Therapeutics GmbH | 13 | 2015-04-01 | 2018-02-28 |
Glaucoma (1) · Glaucoma, Open-Angle (1)
Germany (1)
2014 (1)